Not logged in
Share
SaveLow-dose abiraterone plus Olaparib as a late-line treatment for mCRPC patients without BRCA1/2 mutations: a multicenter retrospective pilot study
Chen, Sijin; Zhong, Dewen; Yu, Chenbo; Cai, Desheng; Wei, Qichen; Yang, Minggen; Li, Tao; Zhu, Qingguo; Ye, Liefu; Wei, Yongbao; Wu, Jinfeng
Share
Save
Share
Save
Share
Save